How do I buy Corcept Therapeutics (CORT) stock?

You can purchase shares of Corcept Therapeutics (NASDAQ:CORT) through any online brokerage.View our list of the best stock brokerages

Who are Corcept Therapeutics (CORT) competitors?

Other companies in Corcept Therapeutics’s space includes: WAVE Life Sciences Ltd (NASDAQ:WVE), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and Ocular Therapeutix Inc (NASDAQ:OCUL).

What is the forecast, or price target, for Corcept Therapeutics (CORT) stock?

Corcept Therapeutics has a consensus price target of $78.88.

What is the current price for Corcept Therapeutics (CORT)?

The stock price for Corcept Therapeutics (NASDAQ: CORT) is $34.83 last updated January 16, 2026 at 6:22 PM EST.

Does Corcept Therapeutics (CORT) pay a dividend?

There are no upcoming dividends for Corcept Therapeutics.

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

Corcept Therapeutics does not have any upcoming earnings scheduled.

Is Corcept Therapeutics (CORT) going to split?

There is no upcoming split for Corcept Therapeutics.

What sector and industry does Corcept Therapeutics (CORT) operate in?

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Corcept Therapeutics (CORT) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The ...

Comments